You are currently viewing a new version of our website. To view the old version click .

Rheumato, Volume 4, Issue 2

June 2024 - 3 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (3)

  • Feature Paper
  • Article
  • Open Access
2,140 Views
43 Pages

Multi-Scale Analysis of Lyme Disease Ecology

  • Rebecca Michelle Bingham-Byrne and
  • Esra Ozdenerol

6 May 2024

Lyme disease is a zoonotic infectious disease. Increased public interest in Lyme disease has caused increased efforts by researchers for its surveillance and control. The main concept for this paper is to determine the mammalian species composition o...

  • Feature Paper
  • Review
  • Open Access
3 Citations
9,592 Views
13 Pages

26 April 2024

The spectrum of disorders/phenomena encompassed in the practice of rheumatology is quite broad. In addition, our expertise is typically sought whenever other physicians encounter phenomena outside their knowledge base. While skin alterations typicall...

  • Feature Paper
  • Article
  • Open Access
2,538 Views
12 Pages

Anti-IL-6 Receptor Treatment in Giant Cell Arteritis Patients Reduces Levels of IL-1β-Receptor Antagonist but Not IL-1β

  • Joana J. da Costa,
  • Lisa Christ,
  • Peter M. Villiger,
  • Monique Vogel and
  • Martin F. Bachmann

31 March 2024

This work aimed to investigate a potential link between serum IL-1β levels in patients with giant cell arteritis (GCA) and their responsiveness to combined anti-IL-6 receptor (IL-6R) and glucocorticoid (GC) treatments within the context of two s...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Rheumato - ISSN 2674-0621Creative Common CC BY license